New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pravastatin sodium 10mg;  ;  ;   - tablet - 10 mg - active: pravastatin sodium 10mg       excipient: croscarmellose sodium iron oxide yellow lactose monohydrate magnesium oxide magnesium stearate microcrystalline cellulose povidone - 1. in hypercholesterolemic patients without clinically evident coronary heart disease, pravachol is indicated as an adjunct to diet to reduce the risk of fatal and non-fatal myocardial infarction, need for myocardial revascularisation procedures, and to improve survival by reducing cardiovascular deaths. 2. pravachol is indicated for the reduction of elevated total and ldl-cholesterol levels in patients with primary hypercholesterolaemia when the response to diet and other nonpharmacological measures alone have been inadequate. 3. pravachol is indicated as an adjunct to diet to slow the progressive course of atherosclerosis and reduce the incidence of clinical cardiovascular events in hypercholesterolaemic men under 75 years of age with coronary artery disease.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pravastatin sodium 20mg;  ;  ;   - tablet - 20 mg - active: pravastatin sodium 20mg       excipient: croscarmellose sodium iron oxide yellow lactose monohydrate magnesium oxide magnesium stearate microcrystalline cellulose povidone - 1. in hypercholesterolemic patients without clinically evident coronary heart disease, pravachol is indicated as an adjunct to diet to reduce the risk of fatal and non-fatal myocardial infarction, need for myocardial revascularisation procedures, and to improve survival by reducing cardiovascular deaths. 2. pravachol is indicated for the reduction of elevated total and ldl-cholesterol levels in patients with primary hypercholesterolaemia when the response to diet and other nonpharmacological measures alone have been inadequate. 3. pravachol is indicated as an adjunct to diet to slow the progressive course of atherosclerosis and reduce the incidence of clinical cardiovascular events in hypercholesterolaemic men under 75 years of age with coronary artery disease.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pravastatin sodium 40mg;  ;  ;   - tablet - 40 mg - active: pravastatin sodium 40mg       excipient: croscarmellose sodium iron oxide yellow lactose monohydrate magnesium oxide magnesium stearate microcrystalline cellulose povidone - 1. in hypercholesterolemic patients without clinically evident coronary heart disease, pravachol is indicated as an adjunct to diet to reduce the risk of fatal and non-fatal myocardial infarction, need for myocardial revascularisation procedures, and to improve survival by reducing cardiovascular deaths. 2. pravachol is indicated for the reduction of elevated total and ldl-cholesterol levels in patients with primary hypercholesterolaemia when the response to diet and other nonpharmacological measures alone have been inadequate. 3. pravachol is indicated as an adjunct to diet to slow the progressive course of atherosclerosis and reduce the incidence of clinical cardiovascular events in hypercholesterolaemic men under 75 years of age with coronary artery disease.

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

grochem australia pty ltd - pyrimethanil - suspension concentrate - pyrimethanil pyrimidine active 400.0 g/l - fungicide - grapevine | ornamental (see label) | strawberry | subject to a tolerance test - grey mould - botrytis cinerea | botrytis blight | botrytis rot | bunch rot

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - pravastatin sodium -

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

intervet international b.v. - fluralaner, moxidectin - antiparasitic products, insecticides and repellents, endectocides, milbemycins - cats - for cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites, gastrointestinal nematodes or heartworm. the veterinary medicinal product is exclusively indicated when use against ticks or fleas and one or more of the other target parasites is indicated at the same time.for the treatment of tick and flea infestations in cats providing immediate and persistent flea (ctenocephalides felis) and tick (ixodes ricinus) killing activity for 12 weeks. fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for flea allergy dermatitis (fad).for the treatment of infestations with ear mites (otodectes cynotis).for the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults of toxocara cati) and hookworm (4th stage larvae, immature adults and adults of ancylostoma tubaeforme).when administered repeatedly at a 12-week interval, the product continuously prevents heartworm disease caused by dirofilaria immitis

Israel - Inggeris - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 1000 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - Inggeris - Ministry of Health

intervet ( israel) ltd - fluralaner - spot-on solution - fluralaner 280 mg / 1 ml - for the treatment of tick and flea infestations in dogs.this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and persistent flea (ctenocephalides felis and ctenocephalides canis) killing activity for 12 weeks, and- immediate and persistent tick (ixodes ricinus, rhipicephalus sanguineus and dermacentor reticulatus) killing activity for 12 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - Inggeris - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 112.5 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - Inggeris - Ministry of Health

intervet ( israel) ltd - fluralaner - spot-on solution - fluralaner 280 mg / 1 ml - for the treatment of tick and flea infestations in dogs.this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and persistent flea (ctenocephalides felis and ctenocephalides canis) killing activity for 12 weeks, and- immediate and persistent tick (ixodes ricinus, rhipicephalus sanguineus and dermacentor reticulatus) killing activity for 12 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.